Stock Screener App

Gratuito -

Installare

22.25

1.48% 0.325

Denali Therapeutics Inc (DNLI)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché DNLI Giù? Forum Previsione

Denali Therapeutics Inc Azioni (DNLI) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	0.05% 137.37	137.43	134.96	145.58	123.19
Operating Income/Loss	0.05% -137.37	-137.43	-134.96	-145.58	-123.19
Income/Loss From Continuing Operations Before Tax	1.22% -128.45	-126.90	-124.12	-132.97	-107.19
Income/Loss From Continuing Operations After Tax	1.30% -128.55	-126.90	-124.12	-132.97	-107.19
Net Income/Loss	1.30% -128.55	-126.90	-124.12	-132.97	-107.19
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.45% 0.9469	172.42	171.45	171.22	169.46
Diluted Average Shares	99.45% 0.9469	172.42	171.45	171.22	169.46
Basic Earnings Per Share	1.35% -0.73	-0.74	-0.72	-0.78	-0.63
Diluted Earnings Per Share	1.35% -0.73	-0.74	-0.72	-0.78	-0.63
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

MRNA

$55.25

6.83%

ROIV

$30.59

2.30%

BNTX

$90.59

0.84%

RPRX

$54.30

0.11%

ONC

$260.15

2.03%

RVMD

$157.38

0.51%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters